Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rheumatoid Arthritis
|
2387 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.730 | 0.750 | 4 | 2012 | 2017 | ||||
Crohn Disease
|
1147 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.720 | 0.667 | 3 | 2010 | 2017 | ||||
Ulcerative Colitis
|
827 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.720 | 0.667 | 3 | 2010 | 2017 | ||||
Ankylosing spondylitis
|
609 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Cholangitis, Sclerosing
|
276 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Hepatitis B, Chronic
|
84 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||
Psoriasis
|
705 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Lupus Erythematosus, Systemic
|
1172 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.060 | 0.833 | 6 | 2015 | 2019 | ||||
Multiple Sclerosis
|
1022 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.040 | 1.000 | 4 | 2010 | 2015 | ||||
Behcet Syndrome
|
243 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.030 | 0.667 | 3 | 2012 | 2017 | ||||
Graves Disease
|
352 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.030 | 0.667 | 3 | 2017 | 2019 | ||||
Ischemic stroke
|
704 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.030 | 1.000 | 3 | 2010 | 2019 | ||||
Acute Chest Syndrome
|
135 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.020 | 1.000 | 2 | 2011 | 2014 | ||||
Arteriosclerosis
|
267 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.020 | 1.000 | 2 | 2014 | 2019 | ||||
Atherosclerosis
|
281 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.020 | 1.000 | 2 | 2014 | 2019 | ||||
Autoimmune Diseases
|
428 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.020 | 1.000 | 2 | 2011 | 2016 | ||||
Giant Cell Arteritis
|
78 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.020 | 0.500 | 2 | 2010 | 2017 | ||||
Sarcoidosis
|
787 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.020 | 2 | 2011 | 2017 | |||||
Acute Coronary Syndrome
|
139 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Adult Lymphoma
|
66 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Asthma
|
1536 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.010 | 1 | 2017 | 2017 | |||||
Breast Carcinoma
|
2793 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Carcinoma of lung
|
1204 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
cervical cancer
|
268 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Cervix carcinoma
|
283 | 0.581 | 0.680 | 20 | 46118343 | 5 prime UTR variant | T/C | snv | 0.75 | 0.80 | 0.010 | 1.000 | 1 | 2017 | 2017 |